Sign in
Not yet taking people in United StatesNo phase

Development of an Opioid Withdrawal Clinical Outcome Assessment

Key facts

Who runs it
University of Maryland, Baltimore
Where
Baltimore, United StatesSee the site
Trial code
Status
Not yet recruiting
People taking part
30 people, planned
Starts
1 Dec 2026
Expected to end
30 Sept 2028
Type of study
Observational, 2 groups
Record updated
10 November 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Past year opioid use disorder, determined by (a) enrollment in current treatment for opioid use disorder and/or (b) an opioid-positive saliva test
  • Fluent in English
  • Has experience with opioid withdrawal at least once in the past 30 days

Who cannot take part

  • Previously participated in affiliated Focus Group study
  • Unable to provide informed consent due to cognitive impairment
  • History of psychosis or mania as determined by the MINI
  • Being pregnant or breastfeeding
  • Exhibiting suicidal behavior in the past 30 days as determined by the C-SSRS
  • Circumstances that could interfere with study participation

Where in United States

  • Kahlert Institute for Addiction MedicineBaltimore, United StatesContact: Kelly E Dunn, Ph.D., MBANot yet recruiting

About the trial

What the trial wants to find out

Withdrawal management strategies are currently the most utilized and ubiquitous intervention for opioid use disorder in the US, yet existing measures of opioid withdrawal lack Food and Drug Administration (FDA) qualification. This project will develop and validate a clinical outcome assessment (COA) for opioid withdrawal,essential for standardizing withdrawal mitigation strategies and establishing best practices. In line with the FDA's drug development tool qualification guidelines, our methodological process will involve conducting focus groups with persons with lived experience of opioid withdrawal for concept elicitation, refining these concepts through cognitive interviews, and conducting construct and longitudinal validations of the new assessment in laboratory settings and across diverse treatment contexts.

The 2 groups in the trial

  • WIthdrawal assessment_precipitated session

    Assessment of withdrawal following elicitation

  • Withdrawal assessment_spontaneous

    Assessment of withdrawal during a period of opioid abstinence

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Development of an Opioid Withdrawal Clinical Outcome Assessment Among Persons With Opioid Use Disorder
Record updated
10 November 2026